Stevanato Group (NYSE:STVN) Price Target Cut to $23.50 by Analysts at UBS Group

Stevanato Group (NYSE:STVN) had its price objective lowered by UBS Group from $24.00 to $23.50 in a research report released on Friday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other equities research analysts also recently issued reports on STVN. Wolfe Research assumed coverage on Stevanato Group in a research report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target on the stock. Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Stevanato Group has a consensus rating of “Moderate Buy” and a consensus price target of €27.75 ($30.16).

Stevanato Group Stock Up 4.9 %

Shares of Stevanato Group stock opened at €21.72 ($23.61) on Friday. Stevanato Group has a 12-month low of €16.56 ($18.00) and a 12-month high of €33.49 ($36.40). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The stock has a 50 day moving average price of €21.38 and a two-hundred day moving average price of €20.55. The stock has a market capitalization of $6.58 billion, a P/E ratio of 46.21, a PEG ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting the consensus estimate of €0.20 ($0.22). The business had revenue of €352.68 million during the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Equities analysts expect that Stevanato Group will post 0.5 earnings per share for the current year.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors have recently added to or reduced their stakes in STVN. Van Berkom & Associates Inc. acquired a new position in Stevanato Group in the 4th quarter valued at approximately $39,000. Johnson Financial Group Inc. bought a new stake in shares of Stevanato Group during the fourth quarter valued at approximately $41,000. Wells Fargo & Company MN raised its stake in shares of Stevanato Group by 680.3% in the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock valued at $71,000 after purchasing an additional 2,830 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Stevanato Group by 1,457.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after purchasing an additional 5,291 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after buying an additional 4,965 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.